Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8936919
APP PUB NO 20120040341A1
SERIAL NO

12305742

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to MAGE-3 specific primers and probes for use new diagnostic kits and methods. The invention further relates to immunotherapeutic treatment of specific populations of cancer patients, suffering from MAGE-3 expressing tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SMITHKLINE BEECHAM BIOLOGICALS S.A.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beer, Gabriele Annemarie Penzberg, DE 1 0
Coche, Thierry Rixensart, BE 15 37
Gruselle, Olivier Rixensart, BE 3 6
Salonga, Dennis Research Triangle Park, US 1 0
Stephens, Craig Lawrence Research Triangle Park, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 20, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00